Live tape
Top 8, mentions 7d19,795GOOGL8,128 mentions▲ +0.02INTC2,169 mentions▲ +0.03AAPL1,921 mentions▲ +0.06AMZN1,800 mentions▲ +0.03MSFT1,678 mentions▲ +0.05RDDT1,464 mentions▲ +0.04NVDA1,380 mentions▲ +0.06QQQ1,255 mentions▲ +0.04

Equity · Healthcare

MXCT

NASDAQ

MaxCyte (MXCT)

1.59 USD −7.31% vs prior close
MaxCyte, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for MXCT to draw a line in its place.

Track this symbol on TradingView
Market cap
163.6M USD
Revenue, year to Dec 2025
21.0M USD
EPS, diluted, year to Dec 2025
−0.42 USD
Next earnings
10 Nov 2026
52-week range
0.6759 USD – 1.76 USD
Avg volume
220.6K

as of Oct 30, 2026

Have MaxCyte (MXCT) insiders bought or sold shares recently?

MXCT has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 17 June 2026.

Form 4

Have MaxCyte (MXCT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Mar 2026Swirsky Douglas JCHIEF FINANCIAL OFFICERSell10,1428K USD
10 other filings: grants, exercises, tax withholding and transfers, not trades
ReportedInsiderTypeSharesValue
17 Jun 2026Al-Wakeel Yasir B.DirectorAward30,421
17 Jun 2026BALTHROP PATRICK JDirectorAward30,421
17 Jun 2026Brooke William WDirectorAward30,421
17 Jun 2026Collins CynthiaDirectorAward30,421
17 Jun 2026DOUGLAS RICHARDDirectorAward30,421
17 Jun 2026Erck Stanley CDirectorAward30,421
17 Jun 2026Hemrajani RekhaDirectorAward30,421
17 Jun 2026Johnston John JosephDirectorAward30,421
15 Apr 2026Ahuja ParmeetChief Financial OfficerAward187,500
27 Mar 2026Masoud MaherPresident and CEOAward300,000

Which funds hold MaxCyte (MXCT)?

10 of the 45 institutional funds we track reported a MaxCyte position for the quarter ended 30 Jun 2026 — a combined 11.3M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold MaxCyte (MXCT)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)1,910,8002.4M USD−4.1%
AQR Capital ManagementAdded1,882,7762.3M USD+54.2%
Two Sigma InvestmentsAdded1,462,9411.8M USD+140.6%
Millennium ManagementAdded1,204,9211.5M USD+2,698.3%
Marshall WaceAdded1,014,7781.2M USD+925.9%
Citadel AdvisorsAdded856,3181.1M USD+157.1%
Man GroupNew position448,958552K USD
Point72 Asset ManagementNew position299,853369K USD
Tudor Investment CorpNew position78,31396K USD
Balyasny Asset ManagementNew position13,54817K USD

What has been filed or recorded for MaxCyte (MXCT)?

The filings we hold for MaxCyte, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Jun 2026. Next report: 10 Nov 2026.

What has been filed or recorded for MaxCyte (MXCT)?
And
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.08 USDRevenue $7M
30 Jun 2026FinancialsTotal assets184.7M USDat period end
30 Jun 2026FinancialsTotal equity158.8M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.04 USDRevenue $10M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.42 USDRevenue $33M
31 Dec 2025FinancialsRevenue21.0M USDfiscal year
31 Dec 2025FinancialsNet income−44.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.42 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.12 USDRevenue $7M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.12 USDRevenue $9M
31 Mar 2025Quarterly earningsQ1 2026 reportedEPS −0.10 USDRevenue $10M
31 Dec 2024Annual reportFY 2024 reportedEPS −0.39 USDRevenue $39M
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.11 USDRevenue $8M

MaxCyte (MXCT): frequently asked questions

From live data
163.6M

What is MaxCyte’s market cap?

MaxCyte is worth 163.6M USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.

21.0M

What is MaxCyte’s revenue?

MaxCyte reported revenue of 21.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have MaxCyte insiders bought or sold shares recently?

No MaxCyte insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 17 Jun 2026 (SEC Form 4). See Insiders

10 of 45

Which funds own MaxCyte?

10 of the 45 funds we track reported a MaxCyte position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, AQR Capital Management and Two Sigma Investments. See Funds

−0.08

When did MaxCyte last report earnings?

MaxCyte last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.08 USD; the next report is scheduled for 10 Nov 2026 (SEC filings). See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  6. SEC EDGARreported earnings figures and scheduled report dates
  7. SEC EDGARValuation computed from SEC EDGAR filings